Wang, J.

LBA33 A first-in-human phase I study of a novel KRAS G12D inhibitor HRS-4642 in patients with advanced solid tumors harboring KRAS G12D mutation

Zhou, C., Li, W., Song, Z., Zhang, Y., Zhang, Y., Huang, D., Yang, Z., Zhou, M., Mao, R., Huang, C., et al. (2023) · Annals of Oncology

Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

Cited by 59